Tenax Therapeutics, Inc. Profile Avatar - Palmy Investing

Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that …

Biotechnology
US, Morrisville [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Tenax Therapeutics, Inc. can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
3,408,910
Volume
12,923
Volume on Avg.
68,183
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $6.48 per share Last Form/Filing Last Transaction
10% Holder
Dellora Investments Lp
Uncategorized SEC Entity
View the form. Palmy doesn't track derivative holdings.
Rich Stuart
Internal : Chief Medical Officer
0 $0
12/06/21
Doogan Declan
Internal : Director
3,637,871 $23,573,404.08
06/15/21
Officers/Directors Below 10%
Rich Stuart
Internal : Chief Medical Officer
662,517 $4,293,110.16
01/27/21
A
662,517 x $0 = $0
Proehl Gerald T
Internal : Director
1,667 $10,802.16
08/08/24
P
1,666 x $0 = $0
Hunter Robyn
Internal : Director
0 $0
06/10/22
0 x $0 = $0
Giordano Christopher Thomas
Internal : CEO
0 $0
12/12/24
0 x $0 = $0
Doogan Declan
Internal : Director
0 $0
12/12/24
0 x $0 = $0
Davidson Michael H.
Internal : Director
0 $0
06/10/22
0 x $0 = $0
Almenoff June Sherie
Internal : Director
0 $0
04/12/22
0 x $0 = $0
Mcgauley Thomas
Internal : Interim CFO
0 $0
12/06/24
0 x $0 = $0
Hoffman Lawrence R
Internal : Interim CFO
0 $0
01/12/24
0 x $0 = $0
Lurier Eliot M
Internal : Interim CFO
0 $0
11/04/21
0 x $0 = $0
Ditonno Anthony A
Internal : CEO
0 $0
01/12/21
0 x $0 = $0
Mitchum James P.
Internal : Director
0 $0
06/15/21
0 x $0 = $0
Jebsen Michael B
Internal : CFO
0 $0
01/12/21
0 x $0 = $0
End of TENX's Analysis
CIK: 34956 CUSIP: 88032L209 ISIN: US88032L6056 LEI: - UEI: -
Secondary Listings
TENX has no secondary listings inside our databases.